Ropes & Gray

Aon to acquire NFP, a leading middle-market provider of risk, benefits, wealth and retirement plan advisory solutions

Retrieved on: 
Wednesday, December 20, 2023
Slate, UBS, Workforce, Vahe, Partnership, Cravath, Swaine & Moore, Risk, TD Securities, EPS, Interest, Jefferies Group, Acquisition, LLP, MDP, Ropes & Gray, HPS, Citigroup, BofA Securities, Madison Dearborn Partners, Aon (company), AON, NFP, Growth, Investment, McDermott Will & Emery, Financial services

The acquisition of NFP expands Aon's presence in the large and fast-growing middle-market segment, with capabilities across risk, benefits, wealth and retirement plan advisory.

Key Points: 
  • The acquisition of NFP expands Aon's presence in the large and fast-growing middle-market segment, with capabilities across risk, benefits, wealth and retirement plan advisory.
  • "We have continually evolved our leading capabilities to better serve our clients' growing needs amidst increasing volatility across the marketplace," said Greg Case, CEO of Aon.
  • "The acquisition will advance our relevance to clients, create opportunities for our colleagues and further strengthen our shared cultural values.
  • NFP is a leader in property and casualty brokerage, benefits consulting, wealth management and retirement plan consulting for middle-market clients with more than 7,700 colleagues.

Aon to acquire NFP, a leading middle-market provider of risk, benefits, wealth and retirement plan advisory solutions

Retrieved on: 
Wednesday, December 20, 2023
Slate, UBS, Workforce, Vahe, Partnership, Cravath, Swaine & Moore, Risk, TD Securities, EPS, Interest, Jefferies Group, Acquisition, LLP, MDP, Ropes & Gray, HPS, Citigroup, BofA Securities, Madison Dearborn Partners, Aon (company), AON, NFP, Growth, Investment, McDermott Will & Emery, Financial services

The acquisition of NFP expands Aon's presence in the large and fast-growing middle-market segment, with capabilities across risk, benefits, wealth and retirement plan advisory.

Key Points: 
  • The acquisition of NFP expands Aon's presence in the large and fast-growing middle-market segment, with capabilities across risk, benefits, wealth and retirement plan advisory.
  • "We have continually evolved our leading capabilities to better serve our clients' growing needs amidst increasing volatility across the marketplace," said Greg Case, CEO of Aon.
  • "The acquisition will advance our relevance to clients, create opportunities for our colleagues and further strengthen our shared cultural values.
  • NFP is a leader in property and casualty brokerage, benefits consulting, wealth management and retirement plan consulting for middle-market clients with more than 7,700 colleagues.

Compass Diversified Completes Sale of Marucci Sports

Retrieved on: 
Wednesday, November 15, 2023
Sale, NYSE, LLP, Marucci Sports, Fox Factory, FOX, Ropes & Gray, Jefferies Group, Partnership, Marucci

The sale price was based on an enterprise value of $572 million, subject to certain working capital and other adjustments.

Key Points: 
  • The sale price was based on an enterprise value of $572 million, subject to certain working capital and other adjustments.
  • This amount was in respect of its debt and equity interests in Marucci and the payment of accrued interest.
  • As previously announced, CODI expects to record a pre-tax gain of approximately $225 million to $245 million from the sale.
  • Elias Sabo, CEO of Compass Diversified, stated, “We are pleased to complete our sale of Marucci Sports and believe the Marucci team is well-positioned for future success under FOX ownership.

Nippon Steel Corporation (NSC) to Acquire U. S. Steel, Moving Forward Together as the ‘Best Steelmaker with World-Leading Capabilities’

Retrieved on: 
Monday, December 18, 2023
Sustainability, Environment, Manufacturing, Steel, NSC, Moving Forward Together, Carbon, Community, Acquisition, NYSE, Safety, Citigroup, Carbon footprint, Hydrogen, Workforce, Recycling, Supply chain, Nippon Steel, Multimedia, Calendar, Goldman Sachs, Ropes & Gray, U.S. Steel, TSE, Evercore, United Steelworkers, Growth, ASEAN, Address, Workplace, Coal, Clothing

The transaction has been unanimously approved by the Board of Directors of both NSC and U. S. Steel.

Key Points: 
  • The transaction has been unanimously approved by the Board of Directors of both NSC and U. S. Steel.
  • For customers, U. S. Steel and NSC create a truly global steel company with combined capabilities and innovation capable of meeting our customers’ evolving needs.
  • U. S. Steel has long been one of America’s steel industry leaders, while NSC has been serving U.S. customers successfully for decades.
  • Milbank LLP and Wachtell, Lipton, Rosen & Katz are acting as legal advisors to U. S. Steel.

Blackstone Real Estate Debt Strategies, Blackstone Real Estate Income Trust, CPP Investments and Rialto Capital Acquire a 20% Equity Stake in a Venture Holding Approximately $17 Billion Commercial Real Estate Loan Portfolio of Former Signature Bank

Retrieved on: 
Thursday, December 14, 2023
Asset Management, Professional Services, Finance, Gibson Dunn, Federal Deposit Insurance Corporation, CPP Investment Board, Investment, Simpson Thacher & Bartlett, Multimedia, Signature Bank, Ropes & Gray, CRE, FDIC, Partnership, CPP, Financial services, Real estate

The FDIC is maintaining an 80% ownership stake in the venture and provided financing equal to 50% of the venture’s value.

Key Points: 
  • The FDIC is maintaining an 80% ownership stake in the venture and provided financing equal to 50% of the venture’s value.
  • Blackstone is the largest owner of commercial real estate globally and has originated or acquired more than $170 billion of real estate loans and securities since the inception of its real estate credit business.
  • Rialto Capital has oversight of over $100 billion of commercial real estate loans and has experience managing public private partnerships.
  • Jones Lang LaSalle served as real estate advisor to Blackstone, CPP Investments and Rialto Capital.

1440 Foods, Leading Portfolio of Sports and Active Nutrition Brands, to Accelerate Growth with Significant Investment from Bain Capital Private Equity, Alongside Existing Investor 4x4 Capital

Retrieved on: 
Wednesday, December 13, 2023
Professional Services, Retail, Health, Fitness & Nutrition, Finance, Vitamins, Supplements, Food, Beverage, Ropes & Gray, KPMG, PJT Partners, Powder, Bountiful, Multimedia, Bain Capital, Partner, Capital, Partnership, UBS, Growth, The Bountiful Company, Sport, Fortress Investment Group, Azania

1440 Foods , (“1440”, or the “Company”), a leading portfolio of sports and active nutrition brands, today announced the signing of a definitive agreement for Bain Capital Private Equity (“Bain Capital”) to acquire a significant stake in the Company, in partnership with existing investor and operator 4x4 Capital .

Key Points: 
  • 1440 Foods , (“1440”, or the “Company”), a leading portfolio of sports and active nutrition brands, today announced the signing of a definitive agreement for Bain Capital Private Equity (“Bain Capital”) to acquire a significant stake in the Company, in partnership with existing investor and operator 4x4 Capital .
  • 1440 Foods will continue to be led by Chief Executive Officer Azania Andrews and her current management team.
  • UBS Investment Bank is serving as financial advisor, KPMG is serving as accounting advisor, and Ropes & Gray is serving as legal counsel to Bain Capital.
  • PJT Partners is serving as financial advisor and Sidley Austin is serving as legal counsel to 1440 Foods and 4x4 Capital.

The Rise Fund to Make Majority Investment in Outcomes First Group Joined by Investcorp

Retrieved on: 
Tuesday, December 12, 2023
Banking, Mental Health, Fund Raising, General Health, Professional Services, Foundation, Philanthropy, People with Disabilities, Consumer, Clinical Trials, Health, Other Philanthropy, Other Education, Continuing, Education, Socially Responsible Investing, Finance, Funding, Ropes & Gray, SEN, Moelis & Company, DLA Piper, OFG, Investment, Stirling Square Capital Partners, Piper, Student, FirstGroup, Learning, Rise, Neuro, Venture capital financing, Stirling Square, Special, Occupational therapy, Private equity, Partnership, Ofsted, Growth, Mental health, Gibson Dunn, Parent, Spectrum, The Rise, Mental, Outcomes First Group, Nursing, Renewable energy, Outcome, Employment, Investcorp

The Rise Fund is making a majority investment in OFG with Investcorp making a minority investment.

Key Points: 
  • The Rise Fund is making a majority investment in OFG with Investcorp making a minority investment.
  • “This is the start of an exciting new chapter for Outcomes First Group,” said David Leatherbarrow, CEO of Outcomes First Group.
  • Moelis & Company served as financial advisor to The Rise Fund and Investcorp in relation to the transaction.
  • Ropes & Gray and Gibson, Dunn & Crutcher served as legal counsel to The Rise Fund and Investcorp respectively.

Carisk® Partners Recapitalizes with Lee Equity Partners and Elements Health Investors

Retrieved on: 
Monday, December 4, 2023
Insurance, Human Resources, Managed Care, Finance, General Health, Health, Professional Services, Health Insurance, Investment, Element, Partner, Lee Equity Partners, Mental health, Ropes & Gray, Health equity, Multimedia, Injury

Carisk Partners (“Carisk”), a specialty risk transfer and care coordination company, announced today the completion of a recapitalization led by Lee Equity Partners, LLC (“Lee Equity”) and Elements Health Investors, LLC (“Elements”).

Key Points: 
  • Carisk Partners (“Carisk”), a specialty risk transfer and care coordination company, announced today the completion of a recapitalization led by Lee Equity Partners, LLC (“Lee Equity”) and Elements Health Investors, LLC (“Elements”).
  • View the full release here: https://www.businesswire.com/news/home/20231204589710/en/
    Previously, an MBF Healthcare Partners portfolio company, Carisk Partners is a leader in the workers’ compensation marketplace.
  • Carisk’s unique clinical model takes a whole-person approach, addressing social determinants of health and health equity, which ultimately drives superior outcomes.
  • Lee Equity Partners has a proven track record of partnering with management teams to build market leading businesses.

QPS Holdings, LLC divests its Neuropharmacology Business Unit

Retrieved on: 
Thursday, November 30, 2023
Research, Finance, Neurology, Clinical Trials, Professional Services, Health, Pharmaceutical, Other Science, Science, CNS, Sale, Contract research organization, Lincoln International, Acquisition, Ropes & Gray, QPS, KPMG, Perella Weinberg Partners, Multimedia, Neuropharmacology, DSM-IV codes, L.E.K. Consulting, Drug discovery, CMC, EY, Czech Republic, Drug development, Pharmaceutical industry, Nordic

Today QPS Holdings, LLC (QPS) a leading drug development Contract Research Organization (CRO), announces an agreement to sell its Neuropharmacology business unit (QPS Neuropharmacology) to Scantox, a leading Nordic pre-clinical, GLP-accredited CRO.

Key Points: 
  • Today QPS Holdings, LLC (QPS) a leading drug development Contract Research Organization (CRO), announces an agreement to sell its Neuropharmacology business unit (QPS Neuropharmacology) to Scantox, a leading Nordic pre-clinical, GLP-accredited CRO.
  • QPS Neuropharmacology, based in Grambach, Austria and focused on drug discovery, specializes in neurodegenerative diseases, rare diseases and mental disorders.
  • QPS Neuropharmacology is based in a 2,700 m2 state-of-the-art facility in Grambach, Austria, and employs more than 80 employees.
  • We believe that the neuropharmacology unit will be strengthened and continue to grow as part of the Scantox organization” says Ben Chien, President and CEO of QPS Holdings, LLC.

Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors

Retrieved on: 
Wednesday, November 29, 2023
Research, Legal, Finance, Clinical Trials, Professional Services, Biotechnology, General Health, Pharmaceutical, Health, Science, Merck & Co., Acquisition, Ropes & Gray, General counsel, GOSS, Entrepreneurship, Executive, Gossamer, Pulmonary hypertension, Doctor of Philosophy, Bristol Myers Squibb, Orthostatic hypertension, Merck, Stanford University, Harvard College, Acceleron Pharma, Massachusetts Institute of Technology, Harvard Law School, Corporate development, PAH, Biology, Pharmaceutical industry, Management, Acceleron

Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH), today announced the appointment of John Quisel, J.D., Ph.D., President and CEO of Disc Medicine, to its Board of Directors.

Key Points: 
  • Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH), today announced the appointment of John Quisel, J.D., Ph.D., President and CEO of Disc Medicine, to its Board of Directors.
  • “Today, we are thrilled to announce that Dr. John Quisel has joined the Gossamer team," said Faheem Hasnain, Chairman, Co-Founder and CEO of Gossamer Bio.
  • We are confident that Dr. Quisel’s appointment enhances our ability to get seralutinib to patients.”
    “I am honored to join Gossamer’s Board at this pivotal moment for the Company,” said Dr. Quisel.
  • During his tenure, Dr. Quisel also served in various roles, including Senior Vice President of Corporate Development and General Counsel.